MR. ALAN DIVINE M.D. NPI 1104825280

NPI Details

MR. Alan Divine, M.D. is an internal medicine in Minneapolis, MN with 46 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. MR. Alan Divine, M.D. NPI is 1104825280. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:1980

The provider's business location address is:

825 S 8TH ST
PARKSIDE PROFESSIONAL BLDG., STE 600
MINNEAPOLIS, MN
ZIP 55404-208
Phone: (612) 339-7171
Fax: (612) 339-2885

The NPI 1104825280 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Hemoglobin a1c level (HCPCS:83036)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, clotting time (HCPCS:85610)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Bilirubin level, direct (HCPCS:82248)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Bacterial colony count, urine (HCPCS:87086)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Urine microalbumin (protein) level (HCPCS:82043)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Uric acid level, blood (HCPCS:84550)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)

The enumeration date for this NPI number is 7/20/2005 and was last updated on 11/10/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.